Objectives To evaluate the efficacy and safety of avacopan in the subgroup of patients with
antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis receiving background …

Abstract Purpose of Review The purpose of this review is to summarize and evaluate most
recent evidence on the epidemiology of infections and associated risk factors in patients with …

Current Opinion in Rheumatology Log in or Register Subscribe to journalSubscribe Get
new issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle …

Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) has been
traditionally treated using glucocorticoids and immunosuppressants. However, these …

Based on the efficacy of intravenous immunoglobulin (IVIg) for the treatment of
antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), we developed a …

Objectives There are limited real-life data regarding the efficacy and safety of rituximab
(RTX) as a remission maintenance agent in microscopic polyangiitis (MPA) and …

Background Immunosuppressive therapies are associated with a risk of infections.
Nevertheless, their incidence in this population remains unclear. This study aims to …

Аннотация Терапия васкулитов, ассоциированных с антинейтрофильными
цитоплазматическими антителами (АНЦА), традиционно проводилась …

Infektionen sind eine wichtige Ursache der Morbidität und Mortalität von PatientInnen mit
entzündlich rheumatischen Erkrankungen. Muskuloskeletale Infektionen stellen hiervon …

Objectives Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a rare
systemic autoimmune disease characterised by inflammation and destruction of small blood …